Back
Bruker Vs. Harvard Bioscience Industry Stock Comparison
Sell
37
BRKR
Bruker
Last Price:
59.41
Seasonality Move:
4.29%
Sell
43
HBIO
Harvard Bioscience
Last Price:
2.37
Seasonality Move:
6.31%
Sell
37
Bruker (BRKR)
is a Sell
Is Bruker a Buy, Sell or Hold?
- The current Bruker [BRKR] share price is $59.35. The Score for BRKR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Harvard Bioscience (HBIO)
is a Sell
Is Harvard Bioscience a Buy, Sell or Hold?
- The current Harvard Bioscience [HBIO] share price is $2.36. The Score for HBIO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- HBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRKR Stock Price Chart
HBIO Stock Price Chart
What is Harvard Bioscience's stock price today?
-
The Harvard Bioscience share price today is $2.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.93 | Sell |
| Relative Strength Index (14 RSI): | 42.27 | Sell |
| Chaikin Money Flow: | 423445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.86 - 65.84) | Sell |
| Bollinger Bands (100): | (61.28 - 66.88) | Sell |
HBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 42.4 | Sell |
| Chaikin Money Flow: | -48491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.35 - 2.51) | Sell |
| Bollinger Bands (100): | (2.52 - 3.1) | Sell |
BRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.32 | Buy |
| 20-day SMA: | 61.13 | Sell |
| 50-day SMA: | 64.14 | Sell |
| 200-day SMA: | 72.11 | Sell |
| 8-day EMA: | 58.96 | Buy |
| 20-day EMA: | 60.8 | Sell |
| 50-day EMA: | 63.1 | Sell |
| 200-day EMA: | 67.96 | Sell |
HBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Sell |
| 20-day SMA: | 2.4 | Sell |
| 50-day SMA: | 2.63 | Sell |
| 200-day SMA: | 3.42 | Sell |
| 8-day EMA: | 2.39 | Sell |
| 20-day EMA: | 2.43 | Sell |
| 50-day EMA: | 2.59 | Sell |
| 200-day EMA: | 3.26 | Sell |
Bruker Earnings Growth & BRKR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.41 per share.
Harvard Bioscience Earnings Growth & HBIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.08 per share.
Bruker Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Harvard Bioscience Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||